Ram Jagannathan

Ram Jagannathan


Research Focus & Metrics

Academic Career Length

10Years (2017-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
20 June 2019 in Current Diabetes Reports
Verified
Journal Article
Closed access
PDF file
RJRam Jagannathan
Ram Jagannathan
SPShivani A. Patel
Shivani A. Patel
MAMohammed K. Ali
Mohammed K. Ali
KNK. M. Venkat Narayan
K. M. Venkat Narayan

1 June 2020 in Diabetes Research and Clinical Practice
Verified
Journal Article
Closed access
MBMichael Bergman
Michael Bergman
MAMuhammad Abdul-Ghani
Muhammad Abdul-Ghani
RDRalph A. A. DeFronzo
Ralph A. A. DeFronzo
Manco MelaniaManco Melania
Manco Melania
GSGiorgio Sesti
Giorgio Sesti
MBMartin Buysschaert
Martin Buysschaert

1 October 2020 in Diabetes, Metabolic Syndrome and Obesity
Verified
Journal Article
Open access
PDF file
RJRam Jagannathan
Ram Jagannathan
JNJoão Sérgio Neves
João Sérgio Neves
BDBrenda Dorcely
Brenda Dorcely
SCStephanie Chung
Stephanie Chung
KTKosuke Tamura
Kosuke Tamura
MBMichael Bergman
Michael Bergman
For over 100 years, the oral glucose tolerance test (OGTT) has been the cornerstone for detecting prediabetes and type 2 diabetes (T2DM). In recent decades, controversies have arisen identifying internationally acceptable cut points using fasting plasma glucose (FPG), 2-h post-load glucose (2-h PG), and/or HbA1c for defining intermediate hyperglycemia (prediabetes). Despite this, there has been a steadfast global consensus of the 2-h PG for defining dysglycemic states during the OGTT. This article reviews the history of the OGTT and recent advances in its application, including the glucose challenge test and mathematical modeling for determining the shape of the glucose curve. Pitfalls of the FPG, 2-h PG during the OGTT, and HbA1c are considered as well. Finally, the associations between the 30-minute and 1-hour plasma glucose (1-h PG) levels derived from the OGTT and incidence of diabetes and its complications will be reviewed. The considerable evidence base supports modifying current screening and diagnostic recommendations with the use of the 1‐h PG. Measurement of the 1‐h PG level could increase the likelihood of identifying high-risk individuals when the pancreatic ß-cell function is substantially more intact with the added practical advantage of potentially replacing the conventional 2‐h OGTT making it more acceptable in the clinical setting.

29 August 2017 in BMC Nephrology
Verified
Journal Article
Open access
PDF file
RJRam Jagannathan
Ram Jagannathan
RPRachel E. Patzer
Rachel E. Patzer
Urbanization is expected to increase in low and middle-income countries (LMICs), and might contribute to the increased disease burden. The association between urbanization and CKD is incompletely understood among LMICs. Recently, Inoue et al., explored the association of urbanization on renal function from the China Health and Nutrition Survey. The study found that individuals living in an urban environment had a higher odds of reduced renal function independent of behavioral and cardiometabolic measures, and this effect increased in a dose dependent manner. In this commentary, we discuss the results of these findings and explain the need for more surveillance studies among LMICs.

27 June 2022 in Diabetes Research and Clinical Practice
Verified
Journal Article
Closed access
RJRam Jagannathan
Ram Jagannathan
TFTeresa Vanessa Fiorentino
Teresa Vanessa Fiorentino
MMMaria Adelaide Marini
Maria Adelaide Marini
GSGiorgio Sesti
Giorgio Sesti
MBMichael Bergman
Michael Bergman

23 June 2022 in Journal of Renal Nutrition
Verified
Journal Article
Closed access
DSDavid St-Jules
David St-Jules
LHLu Hu
Lu Hu
KWKathleen Woolf
Kathleen Woolf
CWChan Wang
Chan Wang
DGDavid S. Goldfarb
David S. Goldfarb
MSMary Ann Sevick
Mary Ann Sevick